Novogen - Still undervalued

NRT stock hasn't moved up enough today to keep in line with US trading in NVGN shares on the Nasdaq.

Last night NVGN traded as high as $2.22 (equivalent ASX price) and closed at $1.98.

So at current prices $1.78 there looks to be some arbitrage. Either NVGN shares will come off or NRT will rise higher. With Novogen undergoing a massive re-rating upwards I will stick my neck out and suggent NRT will match NVGN over the next few days.

Cheers,
Munch.